What question did this study set out to answer?

The study investigates how circVANGL1 contributes to cisplatin resistance in osteosarcoma cells in vitro.

May 8, 2026Discover Oncology0 citationsOpen Access

Exosomal circVANGL1 promotes cisplatin resistance in osteosarcoma cells by regulating the miR-145-5p/E2F3 axis

FMFan MoGuangxi Medical University HWHao WangAnyang Hospital of Traditional Chinese Medicine QXQi XieGuangxi Medical University

Key Points

The study investigates how circVANGL1 contributes to cisplatin resistance in osteosarcoma cells in vitro.
Used osteosarcoma cell lines U2OS and MG-63 and established DDP-resistant models (U2OS-DR and MG-63-DR).
Transfected with circVANGL1 siRNA to silence expression and analyzed effects on proliferation, apoptosis, and miR-145-5p levels.
Performed co-transfection experiments with si-circVANGL1, anti-miR-145-5p, and E2F3 overexpression vector.
CircVANGL1 expression increased by approximately 2.2-fold in U2OS-DR and 2.5-fold in MG-63-DR cells (P < 0.01).
si-circVANGL1 transfection suppressed cell proliferation and DDP resistance while promoting apoptosis.
circVANGL1 interacts with miR-145-5p, influencing the effects of DDP resistance in osteosarcoma.

Abstract

BACKGROUND AND OBJECTIVES: Osteosarcoma (OS) is a malignant bone tumor originating directly from bone tissue, predominantly affecting adolescents. Cisplatin (DDP)-based chemotherapy is commonly used in the treatment of OS, but the emergence of DDP resistance poses a significant challenge to effective management. The study aimed to investigate the role of circRNA VANGL1 (circVANGL1) in mediating DDP resistance in OS in vitro. MATERIALS AND METHODS: The OS cell lines U2OS and MG-63 were used, and DDP-resistant cell models (U2OS-DR and MG-63-DR) were established. Transfection with circVANGL1 siRNA was performed to silence circVANGL1 expression, and its impact on cell proliferation, apoptosis, DDP resistance, and miR-145-5p level was studied. Fluorescence in situ hybridization was employed to localize circVANGL1. TargetScan prediction was utilized to identify the interaction between circVANGL1 and miR-145-5p. Co-transfection experiments of si-circVANGL1 with anti-miR-145-5p or E2F3 overexpression vector (E2F3-oe) were conducted to assess their effects on DDP-resistant cells. RESULTS: Compared to the parental cells, the expression of circVANGL1 was increased by approximately 2.2-fold and 2.5-fold in U2OS-DR and MG-63-DR cells, respectively (P < 0.01). Transfection with si-circVANGL1 effectively suppressed cell proliferation and DDP resistance while promoting apoptosis in DDP-resistant cells. circVANGL1 is transferred via exosomes and primarily localized in the cytoplasm of U2OS and MG-63 cells. TargetScan prediction indicated a target relationship between circVANGL1 and miR-145-5p. Co-transfection of si-circVANGL1 with anti-miR-145-5p or E2F3-oe counteracted the changes in proliferation and apoptosis observed with si-circVANGL1 transfection alone in DDP-resistant cells. CONCLUSION: In vitro findings preliminarily suggest that exosomal circVANGL1 may promote DDP resistance in OS cells by regulating the miR-145-5p/E2F3 axis.

Ask AI

Helpful

Bookmark

View Full Paper